GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

Pfizer's CEO discussed the extensive due diligence the company has conducted on the 3SBio PD-1xVEGF deal. | Pfizer's CEO ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

Trojan horse’ treatment given green light for NHS use - The NHS will be the first health system in the world to roll out the ...

This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...

GSK said it licensed its Shigella vaccine candidate, altaltSonflex1-2-3, to Bharat Biotech International.

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

For patients with advanced or recurrent endometrial cancer, dostarlimab plus carboplatin-paclitaxel treatment is associated ...